International comparison of C-peptide measurements

Clinical Chemistry

Volumn 53, Issue 4, 2007, Pages 784-787

  Wiedmeyer, Hsiao Mei ^a   Polonsky, Kenneth S ^b   Myers, Gary L ^c   Little, Randie R ^a   Greenbaum, Carla J ^d   Goldstein, David E ^a   Palmer, Jerry P ^e  

^a University of Missouri   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d BENAROYA RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HEPARIN; INSULIN;

ARTICLE; CALIBRATION; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; DIABETES MELLITUS; HUMAN; INSULIN RELEASE; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; PROTEIN ANALYSIS;

BIOLOGICAL MARKERS; C-PEPTIDE; CLINICAL CHEMISTRY TESTS; HUMANS; INTERNATIONAL COOPERATION;

EID: 34147220561     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.081570     Document Type: Article

References (15)

1. Polonsky, KS, Licinio-Paixao J, Given BD, Pugh W, Galloway RJ, Karrison T, et al. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type 1 diabetic patients. J Clin Invest 1986;77:98-105.
2. Kjems LL, Volund A, Madsbad S. Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods. Diabetologia 2001;44:1339-48.
3. Wahren J, Jornvall H. C-peptide makes a comeback. Diabetes Metab Res Rev 2003;19:345-7.
4. Johansson JW, Wallberg-Henriksson H, Linde B, Fernqvist-Forbes E, Zierath JR. C-peptide revisited-new physiological effects and therapeutic implications. J Intern Med 1996;240:115-24.
5. Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 1996;39:687-95.
6. Saddig C, Bender R, Starke A. A new classification plot for the C-peptide suppression test. JOP 2002;3:16-25.
7. Miller WG, Myers GL, Rey R. Why commutability matters. Clin Chem 2006;52:553-4.
8. WHO synthetic C-peptide reference material 84/510, National Institute for Biological Standards and Control (UK).
9. Bristow AF, Gaines Das RE. WHO International reference reagents for human proinsulin and human insulin C-peptide. J Biol Stand 1988;16:179-86.
10. Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-related complications in the diabetes control and complication trial. Diabetes Care 2003;26:832-6.
11. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002;346:1685-91.
12. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomized controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004;363:925-31.
13. Stockl D, Franzini C, Kratochvilla J, Middle J, Ricos C, Thienpont LM. Current stage of standardization of measurements of specific polypeptides and proteins discussed in light of steps needed towards a comprehensive measurement system. Eur J Clin Chem Clin Biochem 1997;35:719-32.
14. Rodríguez-Cabaleiro D, Stöckl D, Kaufman JM, Fiers T, Thienpont LM. Feasibility of standardization of serum C-peptide immunoassays with isotope dilution-liquid chromatography-tandem mass spectrometry. Clin Chem 2006;52:1193-5.
15. Rogatsky E, Balent B, Goswami G, Tomuta V, Jayatillake H, Cruikshank G, et al. Sensitive quantitative analysis of C-peptide in human plasma by 2-dimensional liquid chromatography-mass spectrometry isotope-dilution assay. Clin Chem 2006;52:872-9.